Chemical Industry Roche’s Tecentriq Secures Landmark FDA Approval as First Immunotherapy for dMMR Colon Cancer OAKLAND, CA — In a milestone development for gastrointestinal oncology, Swiss pharmaceutical giant Roche has… Laily UPNOctober 11, 2026
